Development of small molecule inhibitors targeting TGF-beta ligand and receptor: Structures, mechanism, preclinical studies and clinical usage
Transforming growth factor-beta (TGF-beta) is a member of a superfamily of pleiotropic proteins that regulate multiple cellular processes such as growth, development and differentiation. Following binding to type I and II TGF-beta serine/threonine kinase receptors, TGF-beta activates downstream sign...
Saved in:
Main Authors: | Wang, Hao, Chen, Meiling, Sang, Xiaohong, You, Xuefu, Wang, Yucheng, Paterson, Ian Charles, Hong, Wei, Yang, Xinyi |
---|---|
Format: | Article |
Published: |
Elsevier
2020
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/36800/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage
by: Wang, Hao, et al.
Published: (2020) -
The development of a novel transforming growth factor-β (TGF-β) inhibitor that disrupts ligand-receptor interactions
by: Wu, Han, et al.
Published: (2020) -
Autophagy is deregulated in cancer-associated fibroblasts from oral cancer and is stimulated during the induction of fibroblast senescence by TGF-beta 1
by: Tan, May Leng, et al.
Published: (2021) -
TGFβ-1 and ALK5 inhibitor treatment affects expressions of TGF β signalling pathway associated molecules in SHED cultured in keratinocyte growth medium
by: Mokhtar@Makhtar, Khairani Idah, et al.
Published: (2015) -
Supplementation of TGF-Beta3 in low serum media promotes chondrogenesis of BMSCs
by: Alfaqeh, Hamoud Hussein Mohammed, et al.
Published: (2017)